Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Source: 
Biopharma Reporter
snippet: 

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).